AGL
agilon health Inc
83.40$
-1.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 85.9% | 85.0% | 87.9% | 87.1% | 86.6% | 84.1% | 85.4% | 84.8% | 83.8% | 86.3% | 87.8% | 89.1% | |
| 7.4% | 6.6% | 5.1% | 5.4% | 7.4% | 11.2% | 7.2% | 10.0% | 10.8% | 13.7% | 9.3% | 6.7% | |
| 24.8% | 28.4% | 18.4% | 18.9% | 19.1% | 23.4% | 19.1% | 19.1% | 19.5% | 22.4% | 15.4% | 11.7% | |
| 59.1% | 54.1% | 67.8% | 66.4% | 65.4% | 58.7% | 64.1% | 61.1% | 59.3% | 53.0% | 59.8% | 66.6% | |
| 0.4% | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| 1.8% | – | – | – | 1.9% | 2.1% | 2.0% | 2.1% | 1.9% | 2.3% | – | – | |
| 2.7% | 1.4% | 1.0% | 1.1% | 1.2% | 1.4% | 1.2% | 1.4% | 1.5% | 3.3% | – | – | |
| 4.1% | 3.7% | 3.1% | 3.5% | 3.5% | 4.2% | 3.5% | 3.8% | 4.7% | 5.2% | 4.1% | 3.8% | |
| 61.7% | 62.0% | 70.3% | 68.8% | 72.5% | 72.8% | 74.1% | 76.1% | 80.8% | 90.0% | 87.9% | 85.7% | |
| 57.1% | 56.1% | 65.9% | 64.1% | 67.4% | 66.4% | 71.1% | 72.9% | 77.7% | 84.7% | 84.5% | 82.5% | |
| 0.2% | 0.5% | 0.3% | 0.4% | 0.0% | 0.1% | 1.8% | 2.0% | 2.2% | 1.5% | 1.0% | 0.9% | |
| 56.9% | 55.6% | 65.6% | 63.7% | 67.4% | 66.3% | 69.3% | 70.9% | 9.1% | 83.2% | 83.6% | 17.3% | |
| 1.5% | 1.9% | 1.3% | 1.3% | 1.7% | 2.0% | 0.0% | 0.0% | 0.0% | 1.2% | 1.0% | 1.0% | |
| 38.3% | 38.0% | 29.8% | 31.3% | 27.5% | 27.2% | 25.9% | 23.9% | 19.2% | 10.0% | 12.1% | 14.3% | |
| -48.1% | -76.2% | -57.5% | -63.0% | -70.8% | -91.5% | -81.5% | -98.0% | -112.1% | -155.6% | -128.2% | -120.1% | |
| 0.7% | 0.9% | 0.7% | 0.8% | 0.8% | 1.0% | 0.9% | 1.0% | 1.0% | 1.3% | 1.1% | 1.1% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.